Clinical trials
Phase 2 Inflammation trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 5 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rigshospitalet, Denmark | 3 |
| Christian Hassager | 2 |
| Novo Nordisk A/S | 2 |
| AstraZeneca | 1 |
| GlaxoSmithKline | 1 |
| Herlev and Gentofte Hospital | 1 |
| Hoffmann-La Roche | 1 |
| InflaRx GmbH | 1 |
| Soren Schou Olesen | 1 |
| Thomas Engstrom | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 18 |
| Cardiovascular Diseases | 3 |
| Heart Diseases | 3 |
| Atherosclerosis | 2 |
| Coronary Artery Disease | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Heart Arrest | 2 |
| Hypertension | 2 |
| Hypertrophy, Left Ventricular | 2 |
| Insulin Resistance | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.